Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Neoplasms 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphadenopathy 1 Leukemia, Prolymphocytic 1 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

Temozolomide 41 Radiotherapy 19 Radiation 12 Nivolumab 10 pembrolizumab 8 Magnetic Resonance Spectroscopy 8 Bevacizumab 7 Specimen Handling 6 poly ICLC 4 atezolizumab 4 Lomustine 4 Ipilimumab 4 Surgical Procedures, Operative 3 Photons 3 Immunoglobulin G 3 Disulfides 3 Cyclophosphamide 3 veliparib 2 sargramostim 2 rocakinogene sifuplasmid 2 olaparib 2 niraparib 2 Transurethral Resection of Bladder 2 Surveys and Questionnaires 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 OKN 007 2 Mycophenolic Acid 2 Metformin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glioblastoma × Valganciclovir × Clear all

NCT04116411 2025-12-22

VIGAS2

Karolinska Institutet

Phase 2 Active not recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡